PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
-24.15%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.88B
AUM Growth
-$596M
(-24%)
Cap. Flow
+$46.3M
Cap. Flow
% of AUM
2.47%
Top 10 Holdings %
Top 10 Hldgs %
70.78%
Holding
37
New
1
Increased
21
Reduced
2
Closed
1
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
+$23.6M |
| 2 |
STAAR Surgical
STAA
|
+$20M |
| 3 |
Amicus Therapeutics
FOLD
|
+$9.92M |
| 4 |
CELG
Celgene Corp
CELG
|
+$6.63M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$5.53M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
+$25.2M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$6.3M |
| 3 |
TRVN
Trevena, Inc.
TRVN
|
+$724K |
Sector Composition
| 1 | Healthcare | 91.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$681M
| $9.17M | 0.49% |
398,595
+1,986
| +0.5% | +$45.7K |
|
|
SHPG
27
DELISTED
Shire pic
SHPG
| $8.34M | 0.44% |
47,938
-144,800
| -75% | -$25.2M |
|
|
DRNA
28
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.36M | 0.29% |
500,913
| – | – |
|
|
ALIM
29
DELISTED
Alimera Sciences, Inc.
ALIM
| $2.16M | 0.12% |
200,920
| – | – |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $1.08M | 0.06% |
29,500
| – | – |
|
31
Cytokinetics
CYTK
$6.12B
| $782K | 0.04% |
123,686
| – | – |
|
|
VIRX
32
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $483K | 0.03% |
33,214
| – | – |
|
|
ACGN
33
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $213K | 0.01% |
4,537
| – | – |
|
|
SPHS
34
DELISTED
Sophiris Bio, Inc.
SPHS
| $205K | 0.01% |
247,000
| – | – |
|
|
MLNT
35
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $40K | ﹤0.01% |
10,138
| – | – |
|
36
Ocugen
OCGN
$334M
| $27K | ﹤0.01% |
5,049
| – | – |
|
|
TRVN
37
DELISTED
Trevena, Inc.
TRVN
| – | – |
-546
| Closed | -$724K |
|